P090: Estimating the direct cost and survival benefit of chronic hepatitis C treatment in novel antiviral agent era, Thailand

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|66-66

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 66-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Direct antiviral treatment of chronic hepatitis C in heart transplant recipients

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 20, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Difficult‐to‐cure populations with chronic hepatitis c: Vanishing in the direct‐acting antiviral era?

By  

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 4-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

The clinical significance of drug–drug interactions in the era of direct‐acting anti‐viral agents against chronic hepatitis C

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1365-1372

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiviral treatment of chronic hepatitis C in clinical routine

By Maieron Andreas  

Wiener klinische Wochenschrift, Vol. 122, Iss. 7-8, 2010-04 ,pp. : 237-242

Springer Publishing Company

Access to resources Recommend Favorite

Successful anti‐viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 521-531

John Wiley & Sons Inc

Access to resources Recommend Favorite